L-甘油醛缩丙酮 | 22323-80-4

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: L-甘油醛缩丙酮
• 中文别名: (S)-(+)-2,2-二甲基-1,3-二氧戊环-4-甲醛；(S)-丙酮缩甘油醛；(S)-2,2-二甲基-1,3-二氧戊环-4-甲醛；(S)-(-)-2,2-二甲基-1,3-二氧戊环-4-甲醛
• 英文名称: (4S)-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde
• 英文别名: (S)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde；(S)-glyceraldehyde acetonide；(4S)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
• CAS: 22323-80-4
• 化学式: C₆H₁₀O₃
• 分子量: 130.144
• InChiKey: YSGPYVWACGYQDJ-RXMQYKEDSA-N

物化性质

• 沸点：
  42-44 °C(Press: 13 Torr)
• 密度：
  1.123±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 包装等级：
  III
• 危险类别：
  3
• 危险性防范说明：
  P501,P273,P240,P210,P233,P243,P241,P242,P280,P370+P378,P312,P391,P303+P361+P353,P403+P235
• 危险品运输编号：
  1993
• 危险性描述：
  H303,H411,H225

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: (S)-Glyceraldehyde acetonide, 50% DCM
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H350: May cause cancer
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: (S)-Glyceraldehyde acetonide, 50% DCM
CAS number: 22323-80-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H10O3
Molecular weight: 130.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN1593 Class: 6.1 Packing group: III
Proper shipping name: DICHLOROMETHANE

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  L-甘油醛缩丙酮 在 硫酸 作用下， 生成 L(-)-甘油醛
  参考文献：
  名称：

  Engineering stereocontrol into an aldolase-catalysed reaction

  摘要：

  针对合成应用，开发了一种新型热稳定醛缩酶，并采用了底物工程手段，在自然多底物酶的醛缩反应中引入立体控制。

  DOI：

  10.1039/b413255f
• 作为产物：
  描述：

  L(-)-甘油醛 生成 L-甘油醛缩丙酮
  参考文献：
  名称：

  Heteroatom substituted propanyl derivatives having 5-lipoxygenase

  摘要：

  结构为##STR1##的化合物，其中R.sup.1是一至四个碳原子的烷基，R.sup.2选自(a)一至四个碳原子的烯基，(b)##STR2##(c)##STR3##和(d)##STR4##，是脂氧酶酶的有效抑制剂，从而抑制白三烯的生物合成。这些化合物在治疗或缓解过敏和炎症性疾病状态中很有用。

  公开号：

  US05516795A1

文献信息

• [EN] PHENOTHIAZINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PHÉNOTHIAZINE ET LEURS UTILISATIONS
  申请人：CAMP4 THERAPEUTICS CORP

  公开号：WO2019195789A1

  公开（公告）日：2019-10-10

  The present invention provides phenothiazine compounds, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment of various diseases or conditions, for example ribosomal disorders and ribosomopathies, e.g. Diamond Blackfan anemia (DBA).

  本发明提供了吩噻嗪化合物，其制备方法，包含该化合物的药物组合物，以及在治疗各种疾病或症状中使用该化合物或组合物，例如核糖体紊乱和核糖体病，例如钻石-布莱克范贫血（DBA）。
• Nickel‐Catalyzed, Regio‐ and Enantioselective Benzylic Alkenylation of Olefins with Alkenyl Bromide
  作者：Jiandong Liu、Hegui Gong、Shaolin Zhu

  DOI：10.1002/anie.202012614

  日期：2021.2.19

  A NiH‐catalyzed migratory hydroalkenylation reaction of olefins with alkenyl bromides has been developed, affording benzylic alkenylation products with high yields and excellent chemoselectivity. The mild conditions of the reaction preclude olefinic products from undergoing further isomerization or subsequent alkenylation. Catalytic enantioselective hydroalkenylation of styrenes was achieved by using

  已开发出NiH催化的烯烃与烯基溴化物的迁移性加氢烯基化反应，可提供高收率和出色的化学选择性的苄基烯基化产物。该反应的温和条件阻止烯烃产物进行进一步的异构化或随后的烯基化。通过使用手性双恶唑啉配体实现苯乙烯的催化对映选择性加氢烯基化。
• [EN] 3-'4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL!-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES<br/>[FR] 3-'4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL-N-ARYL-BENZAMIDES EN TANT QU'INHIBITEURS DE LA PRODUCTION DE CYTOKINES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
  申请人：BOEHRINGER INGELHEIM PHARMA

  公开号：WO2005090333A1

  公开（公告）日：2005-09-29

  Disclosed compounds of formula (I), which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

  公开的化合物式(I)，可以抑制与炎症过程有关的细胞因子的产生，因此可用于治疗涉及炎症的疾病和病理状况，如慢性炎症性疾病。还公开了制备这些化合物的方法以及包含这些化合物的药物组合物。
• [EN] 2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER<br/>[FR] DÉRIVÉS DE 2-CYANOISOINDOLINE POUR LE TRAITEMENT DU CANCER
  申请人：MISSION THERAPEUTICS LTD

  公开号：WO2017158388A1

  公开（公告）日：2017-09-21

  The invention relates to novel compounds of formula I which are inhibitors of deubiquitylating enzymes (DUBs) and/or desumoylating enzymes. In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 7 or ubiquitin specific peptidase 7 (USP7). The invention further relates to methods for the preparation of these compounds and to their use in the treatment of cancer.

  这项发明涉及公式I的新化合物，这些化合物是去泛素化酶（DUBs）和/或去泛素化酶的抑制剂。具体来说，该发明涉及抑制泛素C端水解酶7或泛素特异性肽酶7（USP7）。该发明还涉及这些化合物的制备方法以及它们在癌症治疗中的应用。
• Palladium-Catalyzed γ-Selective and Stereospecific Allyl−Aryl Coupling between Acyclic Allylic Esters and Arylboronic Acids
  作者：Hirohisa Ohmiya、Yusuke Makida、Dong Li、Masahito Tanabe、Masaya Sawamura

  DOI：10.1021/ja9092264

  日期：2010.1.20

  Reactions between acyclic (E)-allylic acetates and arylboronic acids in the presence of a palladium catalyst prepared from Pd(OAc)(2), phenanthroline (or bipyridine), and AgSbF(6) (1:1.2:1) proceeded with excellent gamma-selectivity to afford allyl-aryl coupling products with E-configuration. The reactions of alpha-chiral allylic acetates took place with excellent alpha-to-gamma chirality transfer

  在由 Pd(OAc)(2)、菲咯啉（或联吡啶）和 AgSbF(6) (1:1.2:1) 制备的钯催化剂存在下，无环 (E)-烯丙基乙酸酯和芳基硼酸之间的反应进行得非常好γ-选择性提供具有 E-构型的烯丙基-芳基偶联产物。α-手性烯丙基乙酸酯的反应发生了具有顺式立体化学的优异的 α 到 γ 手性转移，以​​产生在苄基位置具有立体中心的烯丙基化芳烃。该反应在烯丙基乙酸酯和芳基硼酸中都可以耐受范围广泛的官能团。此外，肉桂醇衍生物的γ-芳基化得到含有未共轭烯基取代基的墒二芳基烷烃衍生物。该方法的合成效用通过其在 (+)-舍曲林（一种抗抑郁药）的有效合成中的应用得到证明。观察到的 γ-区域选择性和 E-1,3-syn 立体化学基于 Pd(II) 机制进行合理化，该机制涉及阳离子单（酰氧基）钯（II）配合物和芳基硼​​酸之间的金属转移，以及定向碳钯化，然后是 Syn-β -酰氧基消除。与可能的中间体相

表征谱图